Table 1. . Recent promising examples of pathogen-mediated tumor therapy.
Pathogen species/strain | Characteristics | Target cancer | Indication |
---|---|---|---|
Clostridium novyi-NT | Gram-positive, anaerobic, sporulating | Advanced leiomyosarcoma | Tumor regression after several intratumoral applications of spores |
Salmonella typhimurium ssp (VP20009 and Ty21a) | Gram-negative, facultative anaerobe, motile, intracellular | Melanoma, pancreatic cancer | Induction of immune response, tumor colonization, insignificant tumor regression |
BCG | Gram-positive, obligate aerobe, nonmotile, intracellular | Bladder cancer | Approved for bladder cancer management as intravesical BCG therapy, proven to be more effective than intravesical chemotherapy |
T-VEC | Modified HSV, type 1 | Melanoma | T-VEC has recently been approved for the treatment of advanced of melanoma in the USA, Europe and Australia |
Listeria monocytogenes (ANZ-100 and CRS-207) | Gram-positive, facultative anaerobic, intracellular | Solid tumors (liver, lung, pancreas, ovary and pancreatic) | Induction of immune response, insignificant tumor regression |
T-VEC: Talimogene laherparepvec.